BMC Medical Co., Ltd. (SHE:301367)
China · Delayed Price · Currency is CNY 77.27
-2.27 (-2.85%)
At close: Feb 13, 2026
BMC Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 210.27 | 155.38 | 297.34 | 380.3 | 145.68 | 227.86 |
Depreciation & Amortization | 21.04 | 21.04 | 19.4 | 8.74 | 8.81 | 1.87 |
Other Amortization | 5.79 | 5.79 | 3.93 | 2.29 | 1.78 | 1.91 |
Loss (Gain) From Sale of Assets | -0.19 | -0.19 | -0.48 | -0.02 | - | -0.05 |
Asset Writedown & Restructuring Costs | 3.06 | 3.06 | 0.02 | 3.77 | 0.25 | -2 |
Loss (Gain) From Sale of Investments | -60.36 | -60.36 | -57.17 | -14.82 | -8.46 | -6.96 |
Provision & Write-off of Bad Debts | 2.75 | 2.75 | 2.8 | - | - | - |
Other Operating Activities | -137.21 | 13.96 | 13.97 | -10.78 | 3.87 | 2.96 |
Change in Accounts Receivable | -67.95 | -67.95 | -21.97 | -63.53 | -19.68 | 12.55 |
Change in Inventory | 2.86 | 2.86 | 75.06 | -86.08 | -69.78 | -20.13 |
Change in Accounts Payable | 80.68 | 80.68 | -183.63 | 158.51 | 42.54 | 41.32 |
Change in Other Net Operating Assets | - | - | - | - | - | 3.8 |
Operating Cash Flow | 57.81 | 154.08 | 151.11 | 375.21 | 104.4 | 267.41 |
Operating Cash Flow Growth | -76.32% | 1.97% | -59.73% | 259.39% | -60.96% | 638.51% |
Capital Expenditures | -24.5 | -15.93 | -24.12 | -23.75 | -10.03 | -15.43 |
Sale of Property, Plant & Equipment | 0.05 | 0.48 | 0.16 | 0.08 | 0 | 5.65 |
Cash Acquisitions | - | - | - | 5.86 | - | - |
Investment in Securities | 799.25 | -604.87 | 268.44 | -1,859 | -164.85 | -63 |
Other Investing Activities | 55.75 | 19.21 | 57.43 | 1 | - | 5.95 |
Investing Cash Flow | 830.55 | -601.1 | 301.9 | -1,876 | -174.87 | -66.83 |
Short-Term Debt Issued | - | 384.49 | - | - | - | - |
Total Debt Issued | 648.06 | 384.49 | - | - | - | - |
Long-Term Debt Repaid | - | -11.44 | -9.76 | -3.12 | -1.38 | - |
Total Debt Repaid | -507.42 | -11.44 | -9.76 | -3.12 | -1.38 | - |
Net Debt Issued (Repaid) | 140.65 | 373.05 | -9.76 | -3.12 | -1.38 | - |
Issuance of Common Stock | - | - | - | 1,764 | - | 0.23 |
Common Dividends Paid | -42.03 | -65.79 | -128 | - | -28.8 | -12.05 |
Other Financing Activities | -44.77 | -67.33 | -2 | -25.86 | - | - |
Financing Cash Flow | 53.85 | 239.93 | -139.76 | 1,735 | -30.18 | -11.81 |
Foreign Exchange Rate Adjustments | 5.86 | 4.36 | -0.41 | 7.59 | -3.67 | -2.96 |
Net Cash Flow | 948.07 | -202.73 | 312.84 | 241.89 | -104.32 | 185.81 |
Free Cash Flow | 33.3 | 138.16 | 126.98 | 351.46 | 94.38 | 251.99 |
Free Cash Flow Growth | -85.25% | 8.80% | -63.87% | 272.41% | -62.55% | 708.54% |
Free Cash Flow Margin | 3.17% | 16.38% | 11.31% | 24.83% | 14.24% | 44.96% |
Free Cash Flow Per Share | 0.38 | 1.55 | 1.42 | 4.96 | 1.41 | 3.75 |
Cash Income Tax Paid | 43.24 | 3.49 | -5.79 | -77.83 | 2.23 | 39.9 |
Levered Free Cash Flow | -152.53 | 94.07 | 44.8 | 242.34 | 49.67 | 189.9 |
Unlevered Free Cash Flow | -149.35 | 95.85 | 45.65 | 242.63 | 49.8 | 189.9 |
Change in Working Capital | 12.66 | 12.66 | -128.7 | 5.73 | -47.52 | 41.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.